Correlation Between Gelesis Holdings and Milestone Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Gelesis Holdings and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gelesis Holdings and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gelesis Holdings and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Gelesis Holdings and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gelesis Holdings with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gelesis Holdings and Milestone Pharmaceuticals.

Diversification Opportunities for Gelesis Holdings and Milestone Pharmaceuticals

0.0

Correlation Coefficient

Gelesis Holdings  Milestone Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Gelesis and Milestone is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gelesis Holdings and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Gelesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gelesis Holdings are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Gelesis Holdings i.e., Gelesis Holdings and Milestone Pharmaceuticals go up and down completely randomly.

Pair Corralation between Gelesis Holdings and Milestone Pharmaceuticals

If you would invest (100.00) in Gelesis Holdings on March 21, 2024 and sell it today you would earn a total of  100.00  from holding Gelesis Holdings or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Gelesis Holdings  vs.  Milestone Pharmaceuticals

Gelesis Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gelesis Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Gelesis Holdings is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Milestone Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Milestone Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Gelesis Holdings and Milestone Pharmaceuticals

The main advantage of trading using opposite Gelesis Holdings and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gelesis Holdings position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.

The idea behind Gelesis Holdings and Milestone Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.